We would love to hear your thoughts about our site and services, please take our survey here.
According to the RNS released on 3 May 23, "The independent clinical statistical analysis and report is expected to be completed in June, at which time a further update will be provided."
What are the chances of it being released on time? Hopefully it will be positive.
Whenever I try and day trade I get bitten. This share is too unpredictable.
If you are thinking of selling some, maybe keep an eye on the Share Trades tab and if lots of sales start going through, then sell some... Risky in my opinion though.
Although, I am relatively new to investing so take my advice with a pinch of salt.
I'm just going to hold tight.
I have limit sells set up for £1 and £2. Ambitious I know, but I suspect a large divi in the first half of this year from the Phasefocus sales (and sale of Phasefocus as mentioned in one of the RNS's last year).
Not to mention the potential of the CX300.
Why do you think there will be news by the end of the month? The latest RNS stated “Paraytec has designed a short prospective clinical study…. and is expected to start before the end of February”.
There are no promises of an update before the end of Feb and to repeatedly say there will be will only lead to people selling when they don’t get the update they were wrongly expecting.
They do however also state that the clinical study will monitor patients (who are testing positive for Covid) for up to 10 days. I am hoping for news by mid-March, but there are no promises.
If I have missed something feel free to educate me...
Hi Paul, although you don't need to pay for the Plus account, I personally do as I generally have more than a couple of thousand just sat there, which means you earn more in interest than the cost of the subscription fee.